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Abstract: Cataracts, one of the leading causes of preventable blindness worldwide, refers to lens
degradation that is characterized by clouding, with consequent blurry vision. As life expectancies
improve, the number of people affected with cataracts is predicted to increase worldwide, especially
in low-income nations with limited access to surgery. Although cataract surgery is considered safe,
it is associated with some complications such as retinal detachment, warranting a search for cheap,
pharmacological alternatives to the management of this ocular disease. The lens is richly endowed
with a complex system of non-enzymatic and enzymatic antioxidants which scavenge reactive oxygen
species to preserve lens proteins. Depletion and/or failure in this primary antioxidant defense system
contributes to the damage observed in lenticular molecules and their repair mechanisms, ultimately
causing cataracts. Several attempts have been made to counteract experimentally induced cataract
using in vitro, ex vivo, and in vivo techniques. The majority of the anti-cataract compounds tested,
including plant extracts and naturally-occurring compounds, lies in their antioxidant and/or free
radical scavenging and/or anti-inflammatory propensity. In addition to providing an overview of
the pathophysiology of cataracts, this review focuses on the role of various categories of natural and
synthetic compounds on experimentally-induced cataracts.
Keywords: cataracts; lens; lens transparency; lens opacification; lens crystallins; antioxidants;
glutathione; superoxide dismutase

1. Introduction
Cataracts, one of the leading causes of preventable blindness worldwide, refers to lens degradation
that is characterized by clouding, with consequent blurry or hazy vision [1]. There is evidence that
cataracts account for 10.8 million out of 32.4 million blind individuals, and that 35.1 million out of
191 million people with impaired vision globally have this debilitating disease [2]. The prevalence of
cataracts increases exponentially after 40 years of age, ranging from 3.9% among 55–64-year-olds to
92.6% among those 80 years and older [3–5]. In the US, the number of people suffering from cataracts
is projected to double from 24.4 to 50 million by the year 2050 [6]. Epidemiological studies have
elucidated common cataract risk factors to include age, smoking, ultraviolet (UV) radiation, female
gender, steroid consumption, diabetes mellitus, and high body mass index [7,8]. As life expectancies
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improve throughout the globe, the number of people suffering from cataracts is predicted to increase
worldwide [9], especially in low-income nations that lack easy access to cataract surgery, warranting a
search for cheap, pharmacological alternatives to the management of this disease.
1.1. Classification, Signs and Symptoms of Cataracts
Cataracts are classified based upon the etiology of disease and anatomical location of opacity.
Table 1 provides the etiological classification of various forms of cataracts as summarized by Gupta et al.
(2014) [10]. Congenital and developmental cataracts occur during fetal growth or growth of children.
Age-related cataracts are associated with old age and are mainly attributed to oxidative stress. Traumatic,
complicated, and metabolic cataracts are attributed to physical trauma, inflammatory and degenerative
eye disease, and metabolic disease, respectively. On the contrary, toxic, radiation and electrical cataracts
occur due to exposure to toxicants, electromagnetic waves, and high electrical currents.
Table 1. Type of cataract and their respective causes and risks [10].
Type of Cataracts

Causes

Vulnerable Population

Congenital and
developmental

Heredity, gestational maldevelopment of lens,
maternal malnutrition, infection, drugs, radiation,
fetal/infantile factors-anoxia, metabolic disorders, birth
trauma, malnutrition, congenital anomalies, idiopathic

It may occur since birth or
from infancy to adolescence

Age-related

Senescent changes, dehydration, systemic diseases,
smoking, oxidative stress, and lack of essential
dietary elements

Elderly persons, mostly those
over the age of 50 years

Traumatic

Some physical damage to the eye lens capsule,
penetration of foreign object

People working in hazardous
conditions such as welders
and those in glass furnaces

Complicated

Complications of some chronic inflammatory and
degenerative eye diseases

Patients of skin diseases,
allergy, uveitis, glaucoma,
diabetes, emphysema, asthma

Metabolic

Metabolic disorders—diabetes mellitus, galactosemia

Persons deficient in certain
enzymes and hormones

Toxic

Certain toxicants and drugs- Steroids, NSAID’s

People on steroid therapy
and toxic drugs

Radiation and
electrical

Infra-red rays, x-rays, ultra-violet rays,
and powerful electric current

Persons who encounter excess
sunlight, artificial radiations,
high voltage

Used with permission from Gupta VB (2017) [10].

Age-related cataracts can be further classified based upon the anatomical location of opacity within
the lens into nuclear, cortical, and posterior subcapsular cataracts (Figure 1A–D) [11]. Nuclear cataracts
affect the center of the lens, with the lens becoming yellow or brown after hardening (nuclear sclerosis).
Nuclear cataracts are common with older age and are associated with myopia. In contrast, cortical
cataracts affect outer fibers of the lens (around edges of the nucleus) and assume a wedge-shaped
appearance. Cortical cataracts can result in glares but do not alter vision as much as nuclear cataracts
do. Posterior subcapsular cataracts, which affect the posterior cortex of the lens, are observed in
relatively younger patients. This form of cataracts is associated with hyperopia and progresses faster
than nuclear and cortical cataracts. Like cortical cataracts patients, patients with posterior subcapsular
cataracts may experience glare. Posterior subcapsular cataracts are also associated with corticosteroid
use [12]. Shared symptoms across different types of age-related cataracts include clouded or blurred
vision (Figure 2), faded colors, glare, a halo around lights, poor night vision, and frequent prescription
changes for corrective lenses [6,13].
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1.2. Lens Anatomy and Physiology
A review of the anatomy and physiology of the lens is necessary to understand the pathophysiology
of the disease. The lens is a transparent structure that is devoid of any blood supply. Anteriorly,
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the lens surface is covered by a monolayer of epithelial cells. In addition to maintaining lens metabolic
activity, epithelial cells replicate to produce daughter cells, which migrate and differentiate into
fiber cells [14]. Lens fiber cells make up greater than 95% of the lens and are stretched out to form
compact, concentric layers (“shells”), thereby reducing intercellular space (Figure 3) [15]. Superficial
lens fibers are nucleated and are metabolically active while deeper fibers, which make up most
of the lens, are organelle-free with minimal metabolic activity. Interiorly, fiber cells have a high
expression of soluble crystallin proteins but are devoid of nuclei, mitochondria, endoplasm reticulum,
ribosomes, and other organelles [16]. Lens crystallins make up almost 90% of proteins in the mature
lens [17]. In humans, the non-nucleated human lens fiber cells consist of α-crystallins, β-crystallins,
and γ-crystallins (Table 2) [17]. Purification of high-molecular-weight α-crystallin fraction from human
lenses yielded two homologous α-crystallin polypeptides: αA-crystallins and αB-crystallins [18,19].
The α-crystallin proteins account for up to one-third of the total protein in the lens [20]. However,
three γ-crystallins (γC, γD, γS-crystallin), which are also found with five β-crystallin polypeptides
(βB1, βB2, βB3, β A1/A3, βA4) predominate [21]. Table 2 provides a summary of crystallins identified
in human lens according to size, amino acid residues, Gibbs free energy, their encoding genes,
and chromosomal location [17].
Table 2. Crystallins identified in human lens [17].
Protein

Size (Da)

Residues

∆G (kJ/mol)

Gene

Chromosomal Location

αA
αB
βA1
βA2
βA3
βA4
βB1
βB2
βB3
γC
γD
γS

19 909
20 159
23 191
21 964
25 150
22 243
27 892
23 249
24 230
20 747
20 607
20 875

173
175
198
196
215
195
251
204
211
173
173
177

27
21
–
–
58
–
67
49
–
36
69.4
43.9

CRYAA
CRYAB
CRYBA1
CRYBA2
CRYBA1
CRYBA4
CRYBB1
CRYBB2
CRYBB3
CRYGC
CRYGD
CRYGS

21q22.3
11q23.1
17q11.2
2q35
17q11.2
22q12.1
22q12.1
22q11.23
22q11.23
2q33.3
2q33.3
3q27.3

Daltons (Da); Gibbs free energy (∆G [kJ/mol]). Copyright Elsevier (used with permission from Elsevier).

The stability of soluble crystallins is regulated by several protective systems within and surrounding
the lens. Acetylation of N-terminal residues in β- and γ-crystallins confer inherent protection of
these lens proteins from exopeptidases. Additionally, acetylated N-terminal residues of α-crystallin
subunits are buried in the interior of high-molecular-weight α-crystallin aggregate [22], rendering them
inaccessible. The α-crystallin proteins prevent heat induced precipitation of β- and γ-crystallins [20]
and serve as molecular chaperones that cloister misfolded proteins to mitigate pervasive protein
aggregation [19]. Crystallin stability is further enhanced by the temperature difference in the anterior
segment. Anterior portion of the eye is 2 ◦ C lower than total body temperature due to evaporative
cooling from cornea and distance from blood supply [23]. Additionally, ion pumps such as the Na+ /K+
ATPase and Ca2+ ATPase in pre-equatorial epithelium, together with gap junctions and channels such
as aquaporin tightly regulate the homeostatic environment, thereby contributing the stability of lens
crystallins [24]. Since deeper fibers which make up most of the lens are organelle-free, there is minimal
metabolic activity and lower oxygen levels in the central part of the lens, thereby enhancing stability of
lens proteins. Indeed, oxygen concentration in nucleus of lens has been reported to be as low as less
than 10 µM in mammalian lens [25,26]. To this end, studies have shown that exposure of mammalian
eyes to hyperbaric oxygen is associated with the development of nuclear opacities [27,28].
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scavenge reactive oxygen species to protect the lens. Failure in this primary antioxidant defense system
leads to damage to lenticular molecules and their repair mechanisms. Ultimately, the degradation of
lenticular molecules leads to cataracts [40–43].
2.1. Non-Enzymatic Antioxidants
GSH is a tripeptide thiol with a sulfhydryl residue that scavenges hydroperoxides and electrophilic
compounds [44]. Lenticular GSH synthesis occurs in the cortex from the amino acids, glycine, cysteine,
and glutamate. The enzyme, γ-glutamylcysteine synthase catalyzes the first and rate-limiting step in
the biosynthesis of GSH and exerts feedback inhibition in response to GSH levels [44,45]. Incidentally,
the lens has the highest concentration of GSH in the body [46], with the highest quantities being
localized in the cortex, its site of synthesis [47]. GSH has a significant role in lens transparency by
guarding membrane thiol groups which are vital in cation transport and regulation of the electrolyte
balance [48]. Vitamin C is another non-enzymatic antioxidant that plays a vital role in the physiology
of the lens. In a normal human lens, it is present at high concentrations of up to 3 mmol/L, a level
which is 20–60-fold higher than that of the plasma content [49]. Similarly, α-tocopherol is also found in
the normal human lens at 1.6 µg/g of lens tissue [49]. The only carotenoids found in the human lens are
lutein and zeaxanthin. About 74% of these carotenoids are localized in the epithelium and cortex [50].
2.2. Enzymatic Antioxidants
Among enzymatic antioxidants, SOD removes superoxides through one electron dismutation of
superoxide into H2 O2 and oxygen. Three mammalian SOD isoforms have been described based on their
structure, location, and metal-cofactors: the cytosolic copper-zinc (CuZn)-SOD (EC 1.15.1.1) or SOD-1,
the mitochondrial (Mn)-SOD (EC 1.15.1.1) or SOD-2, and the extracellular (EC)-SOD (EC 1.15.1.1)
or SOD-3, which also contains copper and zinc [51]. SOD-1 enzyme is the most prominent isotype
in the lens [52]. The copper ion in the enzyme is involved in dismutation reactions undertaking
alternate oxidation and reduction, while the zinc ion has only a stabilizing role with no activity in
these reactions [53]. The H2 O2 produced as a result of dismutation reaction is removed through the
CAT and GSH-Px systems. GSH-Px removes H2 O2 by using it to oxidize GSH, whereas CAT removes
the H2 O2 through the formation of oxygen and water [45,54,55]. Moreover, GSH disulfide (GSSG) is
converted to a reduced form, GSH using GSH-Px enzyme and the co factor NADPH, from the pentose
phosphate pathway [45,56]. Primate lenses have such robust protective antioxidant mechanisms
that they can withstand incubation in H2 O2 (1 mM), partly due to the high level of GSH-reductase
(GSH-Rx) activity [57]. Additionally, there is a GSH-dependent thioltransferase system, including
a GSH-S-transferase (GST) enzyme that repairs lens protein oxidation by cleaving protein–thiol
groups to maintain a reduced state [58–60]. Lenticular thiol/disulfide homeostasis is upheld and
the protein–protein disulfide bond is also maintained at low levels by the NADPH-dependent
thioredoxin/thioredoxin reductase system [43,58,61,62]. Collectively, these protein and enzyme
antioxidant systems play a vital role in further prevention of crystallin aggregation and the consequent
development of cataracts [30,45,46].
3. Molecular Mechanisms of Cataract Formation
The molecular mechanism of cataract formation has been explained by the “protein aggregation”
and/or “loss of protein solubility” disease models. The “protein aggregation” disease model
hypothesizes that covalent bond damages lens crystallin proteins due to insult to systems that
maintain redox, ionic, and other physiological environment leading to a partial unfolding of crystallin
proteins. Research suggests that several mechanisms, including deamidation, oxidation, glycation,
and truncation of crystallins, contribute to these covalent modifications associated with damage to
lens crystallins [17,63–74]. Consequently, the crystallin proteins lose their native stability to become
unstable molecules that aggregate, thereby shifting the refractive index. Thus, this model is based on
loss of crystallin stability and the tendency of proteins to partially or fully unfold [17,75]. In support
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of this hypothesis, studies on materials from cataractous lens have revealed the presence of multiple
species of lens proteins with higher molecular weight forms due to aggregation and polymerization.
These high molecular weight aggregates cause light scattering in the lens, thereby accounting for lens
opacity [63–74]. The “protein aggregation” cataract disease model is contrary to that proposed for
other protein aggregation diseases such as Alzheimer’s disease, Huntington’s disease and Parkinson’s
disease, where the high molecular weight proteins further aggregate to form plaque deposits in the
affected parts of the CNS [17].
The “loss of solubility” model hypothesizes that aberrant interactions of native crystallins lead
to loss of solubility of crystallins in their native conformations, with consequent precipitation into
protein-rich and protein-poor regions. This ultimately disrupts the short-range order to alter the
refractive index of the lens [75,76]. Some studies have proposed that altered solubility and crystallization
propensity account for hereditary cataract in certain disease states [76–79].
4. Treatments Strategies for Cataracts
4.1. Current Cataract Treatments
Up to date, there is no pharmacological intervention available for the management of cataracts,
leaving surgery as the main option for the treatment of this disease. Among the different surgical
approaches, phacoemulsification is a technique that involves the use of a probe that emits ultrasound
to break up the lens, which is then aspirated through a thin cannula introduced with a smaller
incision in the cornea. Extracapsular cataract extraction, which involves the removal of nucleus and
cortical materials, leaving behind the posterior capsule, is commonly used in developed countries.
This procedure is used for advanced cataract that cannot be removed with phacoemulsification [80].
While intracapsular surgery is not routinely used, it involves surgical removal of the entire lens with
its capsule [81]. Even though cataractous lenses can be surgically removed and replaced with an
artificial intraocular lens, a procedure that has been successful in restoring sight, there are still barriers
to cataracts surgery and eye care in many countries. Indeed, access to surgery remains a challenge
in developing nations, where cataracts are estimated to accounts for 90% of total blindness among
those of lower socioeconomic status [9]. Additionally, intra-operative (e.g., posterior capsular rapture,
zonular weakness, suprachoroidal hemorrhage) and post-operative complications (e.g., posterior
capsular opacification, elevated IOP, persistent anterior uveitis, retinal detachment) still occur [82].
Thus, pharmacological strategies to management of cataracts may play a significant role in regions of
the world where surgical options are limited.
4.2. Potential Pharmacological Treatments for Cataracts
Based on the models of cataract development and the proposed mechanism for its formation,
there have been attempts to use herbal and/or antioxidants, amino acids, and minerals to attenuate the
development of cataracts. Interference with protein aggregation pathway and modulation of chaperone
activity to promote refolding are also among the efforts that have been attempted. Furthermore,
patented approaches involving the following mechanisms are available: inhibition of glycation-specific
mechanisms, phase separation inhibitors, modulators of the TGF-β pathway, and inhibition of matrix
metalloproteinase [83]. This section provides a review of different categories of compounds that have
been evaluated for anti-cataract potential, in vitro, ex vivo and in vivo.
4.2.1. Antioxidants
The role of oxidative stress in the onset and progression of cataractogenesis has been well
described in literature [40,70]. Consequently, antioxidants and free radical scavengers present a
potential therapeutic strategy to the management of cataracts.
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(i) In vitro and ex vivo studies
Typical antioxidants
There is evidence that depletion of GSH affects lens transparency and leads to the development of
cataracts. Indeed, lenticular GSH is essential in preventing oxidative stress elicited by H2 O2 , where
it serves to maintain lens protein sulfhydryl groups in a reduced state, thereby averting formation
of inter- and intra-molecular disulfide cross-linkages. GSH also plays a protective role in membrane
permeability and active transport of lens protein sulfhydryl groups. It regulates calcium influx and
protects lenticular protein from oxidative and osmotic stress [84–86]. Indeed, GSH mitigated lipid
peroxidation and enhanced the activity of SOD, CAT, and GSH-Px enzymes in H2 O2 (10 mM)-induced
cataract formation in cultured goat lenses, ex vivo [87]. There is evidence that endogenous antioxidants,
vitamin C, and GSH attenuated structural crosslinking, oligomerization, and proteolytic instability
of lens crystallins in a lens protein solution exposed to sunlight in the presence of a photosensitizer,
riboflavin [88]. Taken together, these studies affirm the protective role of GSH in the pathophysiology
of the lens.
The carotenoids, lutein and zeaxanthin, and the vitamin E derivative, α-tocopherol, mitigated
an H2 O2 -induced increase in protein oxidation, lipid peroxidation, and DNA damage in human lens
epithelial cells. Moreover, these antioxidants also increased GSH and the GSH:GSSG ratio [89,90].
Interestingly, the vitamins C and E but not the carotenoids, lutein and zeaxanthin, conferred resistance
in H2 O2 -induced depletion of GSH in epithelial cells, in vitro, suggesting that protective effect of
carotenoids was not dependent on the elevation of GSH [89,90]. The vitamin E derivative, α-tocopherol,
prevented the formation and progression of glucose-induced cataract in goat lenses incubated in
artificial aqueous humor. This activity was further supported by the higher Na+ -K+ -ATPase activity
and low lipid peroxidation compared to glucose-only treated lenses [91].
Amifostine, an organic thiophosphate prodrug, is clinically used as a cytoprotective adjuvant in
cancer chemotherapy due to its free radical scavenging capacity and ability to detoxify reactive drug
metabolites [92]. Belkacémi et al. (2001) reported that the active metabolite of amifostin, aminothiol
WR-1065, protected bovine epithelial cells against X-ray radiation of 10 Gy (2 Gy per minute) as
evidenced by the elevation of GSH content, enhanced cell viability, and a decrease in both nuclear
condensation and epithelial cell apoptosis [93].
In the past few decades, an endogenously-derived organosulfur compound that serves as an
essential co-factor for several enzymes in the body, α-lipoic acid, has emerged as a potent antioxidant,
nutritional supplement, and an aldose reductase inhibitor [94,95]. There is evidence that α-lipoic
acid elicits its antioxidant activity by serving as a free radical scavenger and/or stimulating the
biosynthesis of endogenous antioxidants such as GSH [96–98]. To this end, α-lipoic acid mitigated H2 O2
(0.2 mM)-induced lens opacification, apoptosis and lipid peroxidation in cultured Sprague–Dawley
rat lenses, ex vivo. Moreover, in biochemical studies, it enhanced the activity of the endogenous
antioxidants, SOD and GSH-peroxidase in peroxide-treated lens homogenates [99].
Keto acids and amino acid antioxidants
There is evidence that the ketoacids, pyruvate and α-ketoglutarate, which are intricately involved
in several metabolic pathways in the body, possess antioxidant activity in various biological
systems [100–102]. Oxaloacetate functions as an intermediate in several metabolic pathways,
including gluconeogenesis, the glyoxylate cycle, amino acid synthesis and fatty acid synthesis [103].
Both pyruvate and oxaloacetate serve as precursors for the synthesis of several essential and
non-essential amino acids. Interestingly, pyruvate (10 mM), α-ketoglutarate(20 mM), and oxaloacetate
(20 mM) decreased the level of lenticular lipid peroxidation and enhanced activity of GSH-peroxidase
in H2 O2 (10 mM)-induced cataract formation in cultured goat lenses [104]. Similarly, pyruvate
attenuated in H2 O2 (10 mM)-induced lipid peroxidation and enhanced SOD, CAT, and GSH-peroxidase
activity in cultured goat lenses [87]. Moreover, pyruvate prevented H2 O2 -induced insolubilization
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ingestion of certain amino acids has been linked to cataractogenesis in rats [106]. Rathore and Gupta
(2010) evaluated the effect several amino acids, glycine, l-tryptophan, l-tyrosine, l-phenylalanine,
l-histidine, l-lysine, l-arginine, l-cysteine, l-glutamic acid, l-aspartic acid, and l-proline on H2 O2
(1 mM)-induced cataract formation in goat lenses for 24 h. With the exception of l-tyrosine and
l-phenylalanine, all amino acids tested conferred significant protection from peroxide-induced GSH
depletion. Moreover, all amino acids except l-aspartic acid elevated total soluble protein content in
peroxide-treated lenses. Taken together, these data support a protective function for amino acids in the
mammalian lens, ex vivo [107].
l-cysteine is an essential amino acid that serves as a precursor for the biosynthesis of the
tripeptide thiol antioxidant, GSH. N-acetylcysteine, a prodrug for l-cysteine, is well established as
a thiol antioxidant with better bioavailability compared to the parent amino acid. N-acetyl-cysteine
is clinically versatile, being used as an antidote for acetaminophen poisoning and a mucolytic
agent, amongst others [108]. In experimental animals, N-acetylcysteine has been shown to replete
hyperoxia-induced reduction of GSH in rat liver and mitigate hyperglycemia-mediated protein
oxidation in cultured rabbit lens cells, in vitro [109,110]. N-acetylcysteine amide, a derivative
of N-acetylcysteine, exhibits similar antioxidant activity but superior accessibility to intracellular
tissues due to its lipophilicity [111]. Wang et al. (2009) investigated the effect of N-acetylcysteine
amide on hyperoxia-induced cortical opacification in adult New Zealand rabbit lenses, ex vivo.
These workers reported that N-acetylcysteine amide (20 and 40 mM) prevented hyperoxia-induced
cortical opacification and reduction in Na+ -K+ -ATPase activity. Additionally, this compound elicited
an elevation in soluble proteins, GSH and GSH-Rx activity [112]. In other studies, N-acetylcysteine
amide protected rat lenses from dexamethasone-induced cataract formation with a corresponding
elevation in the GSH:GSSG ratio, GSH-Rx activity, and a reduction in lipid peroxidation [113], thereby
affirming the protective role of N-acetylcysteine amide on cataract formation, ex vivo.
Acetyl-l-carnitine is an amine precursor for carnitine, a key player in fatty acid metabolism within
the cell. There is evidence that acetyl-l-carnitine confers protection from oxidative stress in several
biological systems [114,115]. Acetyl-l-carnitine mitigated selenite-induced cataractogenesis in Wistar
rat lenses, ex vivo. Moreover, the activities of CAT, GSH-Px were higher and lipid peroxidation
lower in acetyl-l-carnitine treated lenses, affirming its protective function in selenite-induced
cataractogenesis [116]. Propolis, a compound produced by bees, reduced reactive oxygen species and
increased cell viability in rat epithelial cell cultured with glucose, implicating the role of propolis in
inhibiting hyperglycemia insult-initiated oxidative and osmotic stress [117].
Plant-derived compounds and herbal extracts
There is a large body of evidence supporting the anti-cataract potential of numerous medicinal
plants, presumably via mechanisms that involve antioxidant potency of these plant-derived compounds
and/or extracts. Quercetin, a flavonoid that is present in many fruits, vegetables, and grains, has been
identified as a potent antioxidant and anticancer agent [118,119]. Quercetin prevented cataract
progression and formation in glucose-induced goat lenses incubated in artificial aqueous humor in a
manner that was characterized by a decrease in lipid peroxidation and an increase in Na+ -K+ -ATPase
activity [91]. Chrysin, a flavone found in honey, prevented selenite-induced cataract formation in
cultured Wister rat lenses by modulating genes responsible for calcium transport, calpain activation,
and apoptosis [120]. Chaudhury et al. (2017) also showed that flavonoids from green tea prevented UV
radiation-induced oxidative damage to human γB-crystallin, in vitro [121]. Moreover, a polyphenol
derived from green tea, epigallocatechin-3-gallate (EGCG) attenuated and reversed the aggregation of
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αA(66–80), a peptide fragment derived from αA-crystallin peptide. Since αA(66–80) aggregates play
a role in the destabilization of native crystallin structures, EGCG can potentially prevent onset and
reverse cataract formation [122]. In corroboration, green tea (Camellia sinensis) leaf extract mitigated
Na selenite-induced reduction on SOD, GSH-Px and CAT activities, and increase in lipid peroxidation
in Wistar rat lenses, ex vivo [123]. In general, these studies suggest a protective role for natural
polyphenols and flavonoids in cataract formation.
Drevogenin D is a triterpenoid aglycone derived from Dregea volubilis, a plant which belongs
to the Asclepiedaceae family. Extracts from Dregea volubilis have found medicinal application for
various conditions such as inflammation, asthma, dyspepsia, tumors [124–126]. Biju et al. (2007)
demonstrated an anti-cataract activity of the triterpenoid aglycone, drevogenin D from Dregea volubilis,
in a selenite-induced Sprague–Dawley rat cataract model, ex vivo. Not only did the presence of
drevogenin D mitigate selenite-induced inhibition of SOD, CAT, and GSH-Px enzyme activities, it also
elicited an increase in GSH and sulfhydryl levels and a decrease in lipid peroxidation [127].
Fenugreek (Trigonella foenum-graecum), a leguminous plant that is used globally as a spice, has been
shown to possess multiple beneficial medicinal properties such as antidiabetic, anticarcinogenic,
hypocholesterolemic, antioxidant, and immunological effects [128]. Moreover, the extracts of fenugreek
seed have been shown to possess potent antioxidant and free radical scavenging activities in vitro and
in vivo [129,130]. Using Wistar rat lenses, Gupta et al. (2010a) demonstrated that the aqueous extract
of fenugreek (Trigonella foenum-graecum seeds) could sustain lens transparency and restore lenticular
activities of SOD, GSH-Px, CAT, and GST enzymes in a selenite-induced lens model. Moreover,
this plant extract also blocked selenite-induced depletion of GSH and higher lipid peroxidation in
Wistar rat lenses, ex vivo [131]. Using the same experimental model, Gupta and co-workers also
found that the aqueous extract of the herbal preparation Triphala, made from three fruits of Asian
origin, Emblica officinalis, Terminalia chebula, and Terminalia belerica protected cultured rat lenses from
selenite-insult by maintaining optical clarity, restoring the activity of SOD, GSH-Px, CAT, and GST and
attenuating lipid peroxidation [132]. Although the exact composition of Triphala is variable, this herbal
mixture has been reported to exert multiple beneficial effects in humans [133].
Moringa oleifera, a plant belonging to the Moringaceae family, has found therapeutic application in a
wide range of conditions including epilepsy, fever, hypertension, inflammation, tumors, hyperlipidemia,
and diabetes. Due to enrichment of vitamins A and C and minerals, the Moringa oleifera plant cans serve
as a nutritional supplement and a source of natural antioxidants in malnourished individuals [134,135].
The ethanol extract of Moringa oliefera prevented lens opacification of hyperglycemia (55 mM)-induced
cataract formation up to 72 h. Moreover, Moringa oleifera extracts restored GSH, soluble protein content,
CAT activity, and mitigated lipid peroxidation, ex vivo [136].
Abutilon indicum, a plant that belongs to the Malvaceae family, is an indigenous shrub found in
tropical and subtropical climates in Asia. It is used as a herbal remedy for a wide range of ailments
such as fever, infection, and inflammation [137–139]. Hydroethanolic extracts of Abutilon indicum
effectively attenuated lens opacification in glucose (55 mM)-induced cataract formation in cultured
goat lenses. In these studies, the extract-treated lenses displayed a reduction in malondialdehyde
content and an increase in total protein content and SOD activity. Moreover, the extracts attenuated
aldose reductase activity in hyperglycemia-treated lenses, thereby affirming its anti-cataract activity
in an acute diabetic cataract lens model, ex vivo [140]. In other studies, the ethanol extract of ginger
(Zingiber officinale), a well-known spice, delayed hyperglycemia-induced opacification in cultured goat
lenses, ex vivo. The ginger extract treated lenses also displayed a higher Na+ -K+ -ATPase activity and
total protein content, and a reduction in lipid peroxidation [141].
Hippophae rhamnoides L. is a deciduous shrub of the family Elaeagnaceae that is also known
as Seabuckthorn. Although exact composition varies with geographical location of the plant,
the seabuckthorn plant is enriched with minerals, vitamins, and micronutrients with medicinal
and nutritional value [142]. Leaf extracts of seabucthorn have been shown to possess potent antioxidant
activity in C-6 glioma cells, in vitro [143]. The aqueous extract of seabuckthorn leaf delayed initiation
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and progression of H2 O2 -induced cataract formation and restored GSH, SOD activity in goat lenses,
ex vivo [144].
Abies pindrow, commonly known as west Himalayan fir, is an evergreen tree that belongs to the
Pinaceae family. Leaf extracts of Abies pindrow with demonstrated potent antioxidant activity [145],
have been used as a herbal remedy for various ailments, including fever, diabetes, bronchitis,
and antispasmodic [146]. Dubey et al. (2015a) investigated the anti-cataract activity of the aqueous leaf
extract of Abies pindrow on H2 O2 -induced cataract formation in goat lenses, ex vivo. These investigators
reported that the herbal extract prevented clouding caused by peroxide insult and enhanced GSH
and total protein contents and SOD activity, when compared to peroxide-only treated lenses [147].
In another study, Dubey et al. (2015b) further delineated the role of Luffa cylindrica on cataract formation
in goat lenses, ex vivo. Also known as sponge gourd, Luffa cylindrica is a fibrous plant belonging to
the family Cucurbitaceae. In addition to being consumed globally as a vegetable, the fruit possesses
potent antioxidant properties and is used as a traditional medication for inflammation and diabetes
management, amongst others [148–150]. Dubey (2015b) and coworkers showed that a standardized
preparation of Luffa cylindrica fruit extract protected goat lenses from H2 O2 -induced opacification,
lipid peroxidation, and enhanced total protein content, ex vivo [151].
Ocimum tenuiflorum (also known as Ocimum sanctum) is a perennial plant that is indigenous to
Indian subcontinent that belongs to the Lamiaceae family. Ocimum sanctum is used as a herbal remedy
for various ailments, including inflammation (e.g., arthritis), respiratory problems (e.g., cough, asthma,
bronchitis), malaria, stomach problems (e.g., diarrhea), and ocular pain in some Asian nations [152].
Gupta et al. (2005) found that aqueous extracts of Ocimum sanctum could mitigate selenite-induced
damage to proteins and antioxidant enzymes in rat lenses, ex vivo [153].
In summary, a wide range of compounds and herbal mixtures that possess antioxidant properties
have been shown to protect lenses from oxidative damage, ex vivo and in vitro. For these compounds
to be clinically significant, these studies need to be replicated in vivo. Furthermore, extensive chemical
characterization of the active compounds in the plant-derived products needs to be performed to
determine their pharmacological mechanism/s of action. Table 3 provides a summary of antioxidant
drugs that elicit an anti-cataract effect on various models of the disease, in vitro and ex vivo.
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Table 3. Summary of in vitro and ex vivo studies of cataractogenesis.
Class

Drugs Tested

Cataract Stimuli

Tissue

Pharmacological Action

Ref

GSH

H2 O2 (10 mM)

Goat lenses

Increased lenticular antioxidant defense enzymes and
decreased malondialdehyde levels

[87]

Ascorbic acid and GSH

Incubation in riboflavin and
exposure to sunlight

Bovine lens soluble
proteins

Reduced structural crosslinking and proteolytic instability
of lens crystallins

[88]

Alpha-tocopherol, lutein and
zeaxanthin

H2 O2 (100 µM)

Human lens epithelial
cells

Alpha-tocopherol, lutein and zeaxanthin protected lens
protein, lipid, and DNA from oxidative damage. Unlike
α-tocopherol, lutein and zeaxanthin did not mitigate
GSH depletion.

[89]

Vitamin C or vitamin E

Buthionine sulfoximine
(25–200 µM) treatment
followed by H2 O2 (0–800 µM)

Rabbit lens epithelial
cells

Pretreatment with vitamin C (25–50 µM) or vitamin E
(5–40 µM), restored the resistance of GSH-depleted cells to
H2 O2 upholding GSH in its reduced form.

[90]

Alpha- tocopherol

Glucose (55 mM)

Goat lenses

Increased water-soluble protein content and Na+ -K+ ATPase activity while reducing malondialdehyde levels.

[91]

Aminothiol WR-1065 and
anetholedithiolethione (20 µM)

X-ray irradiation (10 Gy at
rate of 2 Gy/min)

Bovine lens epithelial
cells

Increased GSH levels and cell viability accompanied by
decreased HO fluorescence and lower proportion of cells
with apoptotic morphology.

[93]

Alpha lipoic acid

H2 O2 (0.2 mM)

Adult Sprague-Dawley
rat lenses

Inhibited lens’ epithelial cell apoptosis and activated
lenticular anti-oxidative enzymes.

[99]

Pyruvate, alpha ketoglutarate,
oxaloacetate

H2 O2 (10 mM)

Goat lenses

Pyruvate (10 mM), alpha ketoglutarate (20 mM) and
oxaloacetate (20 mM) decreased lenticular
malondialdehyde while augmenting GSH-Px activity.

[104]

Pyruvate

H2 O2 (10 mM)

Goat lenses

Increased lenticular antioxidant defense enzymes and
decreased malondialdehyde levels

[87]

Pyruvate

H2 O2 (2 mM)

Sprague-Dawley rat
lenses

Decreased water insoluble proteins (urea soluble) level and
prevented loss of gamma crystallin fraction.

[105]

[107]

[112]

Antioxidants

Ketoacids and
amino acid
antioxidants

Ketoacids and amino acids

H2 O2 (1 mM)

Goat lens

All amino acids (1 mM) protected against GSH depletion
except l-tyrosine and l-phenylalanine. All amino acids
prevented oxidative stress-induced lens protein aggregation
except L aspartic acid.

N-acetylcysteine amide

Exposure to hyperoxia-

Rabbit lenses

Increased GSH and water-soluble protein content.
However, it lowered Na+ , K+ -ATPase, and CAT activity.
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Table 3. Cont.
Class

Plant-derived
compounds and
Herbal remedies

Drugs Tested

Cataract Stimuli

Tissue

Pharmacological Action

Ref

N-acetylcysteine amide

Dexamethasone (5 µM)

Sprague-Dawley rat
lenses

Elevated GSH/GSSG ratio and limiting lipid peroxidation

[113]

Acetyl-l-carnitine

Sodium Selenite (100 µM)

Wistar rat lenses

Augmented CAT and GSH-Px activity while reducing
malondialdehyde levels.

[116]

Propolis

Glucose (55 mM)

Rat lens epithelial cells

Propolis (5 and 50 µg/mL) attenuated both the glucose
(55 mM)-induced elevation in the expression of reactive
oxygen species and elevation in cell viability

[117]

Quercetin

Glucose (55 mM)

Goat lenses

Increased water-soluble protein content and Na+ -K+ ATPase activity while reducing malondialdehyde levels.

[91]

[120]

Chrysin, a flavonoid present in
honey

Sodium selenite (100 µM/mL)

Wistar rat lenses

Chrysin (200 µM/mL) prevented cataractogenesis.
Increased activity of calpain and lenticular preferred
calpain (Lp82), as well as mRNA transcript levels of
genes that encode m-calpain and Lp82. Lowered calcium
transporter proteins and lenticular apoptotic-cascade
proteins along with mRNA transcripts of the genes.

Epigallocatechin-3-gallate
(EGCG), a polyphenol derived
from green tea

H2 O2

Human γ-crystallin

EGCG attenuated and reversed peroxide-induced
aggregation of αA(66–80), a peptide fragment
derived from αA-crystallin peptide

[122]

Green tea (Camellia sinensis)
leaves extract

Sodium selenite (100 µM)

Wistar rat lenses

Preserved SOD, GSH-Px, and CAT activities

[123]

Drevogenin D, a triterpenoid
aglycone from Dregeavolubilis

Sodium selenite (100 µM)

Rat lenses

Increased activity of SOD, CAT, GSH-Px, and GSH-Rx.
It augmented the level of reduced GSH and protein
sulfhydryl, while it reduced lipid peroxidation.

[127]

Aqueous extract of
Trigonellafoenum-graecum
(Fenugreek)

Sodium selenite (100 µM)

Wistar rat lenses

Restored GSH and activities of SOD, GSH-Px and GST
while decreasing malondialdehyde levels.

[131]

A herbal preparation—
Triphala (composed of Emblica
officinalis, Terminalia chebula,
and Terminalia belerica)

Sodium selenite (100 µM)

Wistar rat lenses

Restored GSH content and activities of SOD, CAT, GSH-Px
and GST while malondialdehyde levels were decreased.

[132]

Ethanol extract of Moringa
oliefera

Glucose (55 mM)

Goat lenses

Extracts (200 µg/mL and 500 µg/mL) reduced
malondialdehyde levels and increased lenticular CAT,
GSH, total and soluble protein.

[136]
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Table 3. Cont.
Class

Drugs Tested

Cataract Stimuli

Tissue

Pharmacological Action

Ref

Hydro-ethanolic leaf extract of
Abutilon indicum

Glucose (55 mM)

Goat lenses

Extract (500 µg/mL) reduced malondialdehyde level and
increased total protein content and SOD activity.

[140]

Ethanol extract of
Zingiberofficinale

Glucose (55 mM)

Goat lenses

Extract (100, 300, and 500 ng/mL) increased protein (total
and water-soluble proteins) content and Na+ -K+ -ATPase
activity while reducing malondialdehyde levels.

[141]

Aqueous extract of
Seabuckthorn
(Hippophaerhamnoides L.) leaves

H2 O2 (0.5 mM)

Goat lenses

Reinstated the level of SOD and GSH while reducing
malondialdehyde levels

[144]

Aqueous leaf extract of
Abiespindrow

H2 O2

Goat lenses

Extracts (5, 10, 15, and 20 mg/mL) increased SOD, GSH,
total protein content while lowering malondialdehyde
levels proportionally with increase in concentration.

[147]

Fruit extract of Luffa cylindrica

H2 O2 (0.5 mM)

Goat lenses

Increased SOD, GSH, and total protein content while
lowering malondialdehyde content.

[151]

Ocimum sanctum

Sodium selenite (100 µM)

Wistar rat lenses

Increased SOD, GSH-Px, GST, and CAT.

[153]
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(ii) In vivo studies
Various experimental animal models, including the inducible or genetic models of cataracts
have been employed in studies of cataractogenesis, in vivo [154–156]. The induced cataract types
include models for oxidant stress-induced (selenite, naphthalene, I-buthionine-(S,R)-sulfoximine (BSO),
hyperbaric oxygen), diabetic cataract (streptozotocin, galactose, and rat strains with spontaneous
onset diabetes); UV-induced cataract (exposure to UVA and UVB) and steroid-induced opacification
in different animal species [154–156]. Using these in vivo models, different antioxidants have been
evaluated for their anti-cataract activity.
Typical antioxidants
Lenticular vitamin C is a crucial antioxidant and ultraviolet-filter that mitigates entry of light rays
into the lens, thereby minimizing consequences of oxidative damage to the lens [157,158]. Insufficient
consumption of vitamin C elicited a reduction in lenticular levels of ascorbic acid in guinea pigs [159],
while dietary intake of the vitamin was found to increase lenticular ascorbic acid levels in rats [160,
161]. Peighmbarzadeh and Tavana (2014) investigated the effect of vitamin C on selenite-induced
cataractogenesis in New Zealand albino rabbits, in vivo. In this study, cataract was induced by a
single subcutaneous injection of selenite (20 µmol/kg) on the 10th postpartum day. Daily subcutaneous
injection of vitamin C (2.5 mg/rabbit) from the eighth day (postpartum) for 14 days attenuated cataract
formation in 40% of animals [162]. In support of these observations, biochemical studies revealed a
higher level of total soluble protein content compared to selenite-treated animals, thereby affirming
its anti-cataract activity [162]. Using a similar experimental model, Jahadi Hosseini et al. (2008)
demonstrated a 50% protective action for vitamin C (0.3 mM) from selenite-induced cataract formation
in Sprague–Dawley rat pups, in vivo. Biochemical assays confirmed a higher concentration of total
proteins and soluble proteins in vitamin C-treated animal lenses, compared to that of selenite-only
treated animals [163]. Moreover, vitamin C attenuated galactose-induced cataract formation in guinea
pigs [164]. Recently, this vitamin was reported to mitigate selenite-induced cataract formation and the
corresponding loss in chaperone activity in Sprague–Dawley rat pups, in vivo [165]. Taken together,
these studies suggest a partial protective role of vitamin C in experimental cataractogenesis, thereby
affirming the multifactorial etiology of the disease. On the contrary, higher levels of vitamin C have
been shown to serve a pro-oxidant role in mammalian lens, presumably due to its oxidative stress
metabolites such as dehydroascorbic acid [166].
The fat-soluble vitamin, vitamin E, has also been reported to serve as a crucial antioxidant in the lens
defense system. Not only is a deficiency of vitamin E linked to an increase in the risk of cataractogensis
in rats [167,168], but its anti-cataract activity has been demonstrated against selenite-, galactose-,
steroid-, streptozocin- and UV radiation-induced cataract in experimental animals [165,167–171].
Amongst possible mechanisms, vitamin E has been shown to elevate GSH levels and protect the
chaperone activity of crystallin proteins, thereby preserving the antioxidative defense mechanism
within the lens [165,169].
Khan et al. 2017 showed that the potent, endogenous disulfide antioxidant, α-lipoic acid, prevented
the onset and progression of fructose-induced cataract in Sprague–Dawley albino rats. These workers
also found an increase in the level of several antioxidants (GSH-Px, CAT, SOD, and GSH) while lipid
peroxidation was reduced, compared to that of fructose-only treated animals. Interestingly, α-lipoic
acid treatment reinstated lens protein Ca2+ ATPase and Ca2+ in the lens [172]. In other studies, the
anti-cataract effect of α-lipoic acid together with pantethine, penicillamine, and deferoxamine were
attributed to their antioxidant effects [173–176].
The potent pyridoindole antioxidant and free radical scavenger, stobadine, deferred the progression
of streptozocin-induced diabetic cataract in Wistar rats by blocking lipid peroxidation, in vivo [171,177].
In other studies, the endogenous free radical scavenger, melatonin, attenuated BSO-induced cataract
formation in neonatal rats in vivo and enhanced total lenticular GSH content, suggesting that either
the free radical scavenging and/or a stimulatory effect on GSH content was responsible for the
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anti-cataract activity [178]. Taken together, these studies affirm the protective role of antioxidants on
the pathophysiology of the lens, in vivo.
The dietary minerals, zinc and copper, have been reported to prevent cataract formation. Indeed,
copper and zinc are crucial for the activity of the lenticular antioxidant systems such as the cytosolic
SOD-1 enzyme [179,180]. Low lenticular concentrations of zinc have been observed in patients with
mature age-related cataracts and high levels in those with traumatic cataracts [181]. In a recent
study, dietary supplementation with zinc for a period of six weeks mitigated the formation of
streptozocin-induced cataracts in experimental rats [182]. In addition to enhanced levels of α-crystallin
proteins, zinc supplementation attenuated the lenticular expression of polyol pathway enzymes [182].
Topical application of zinc sulfate eye drops has also been reported to attenuate lens opacity induced
by intravitreal injection of sodium selenite in adult rabbits, in vivo [183], supporting an important role
for zinc in lens clarity.
Although selenium is a trace element that plays a significant role in lenses where it supports
the activity of antioxidant selenoproteins such as GSH-Px [184], toxic levels of this element produce
oxidant stress-mediated cataract formation, leading to its application in the induction of experimental
cataracts [154,156]. Karakucuk et al. observed a decrease in the concentration of selenium in the
aqueous humor and lens of patients with age-related cataracts, an important finding that supports the
significant role of selenium in the activity of GSH-Px enzyme in maintaining lens clarity [185]. Ebselen,
an organoselenium molecule that possesses antioxidant, neuroprotective, and anti-inflammatory
activities, protected Sprague–Dawley rat pups from selenite-induced cataracts, in vivo [186,187].
Moreover, the ebselen-treated lenses exhibited clearer lenses, higher lenticular GSH content, and less
lipid peroxidation when compared to that of selenite-only treated animals [187]. Taken together, these
studies confirm the vital antioxidant role of trace elements in maintaining lens transparency, in vivo.
Ketoacids and amino acids antioxidants
The ketoacid, pyruvate, attenuated the progression of streptozotocin- and selenite-induced
cataracts in experimental animal models, in vivo [105,188]. In addition to exhibiting anti-cataract
activity, ex vivo [112], N-acetylcysteine, a prodrug for the amino acid and thiol antioxidant l-cysteine,
has been shown to replicate its anti-cataract activity in vivo. N-acetyl-cysteine inhibited selenite-induced
nuclear opacities in Sprague–Dawley rats, in vivo [189]. Lenticular malondialdehyde and protein
carbonyl levels were lower in lens homogenates from N-acetylcysteine-treated rats while GSH content
was significantly higher compared to that of control animals [189]. Tuzcu et al. (2014) sought to
determine the role of intravitreal triamcinolone acetonide injection on cataract formation in albino
Wistar rats, in vivo. Although there was no visible lens opacification in response to steroid exposure,
N-acetylcysteine protected lenses from the steroid-induced decline in GSH and GSH-Px activity and a
corresponding decline in malondialdehyde and protein carbonyl content, compared to those of control
animals [190].
N-acetylcysteine amide is a more lipophilic derivative of N-acetylcysteine, with superior
bioavailability into intracellular sites. Both N-acetylcysteine amide and glutathione ethyl ester eye
drops delayed onset of streptozotocin-induced cataract formation in Sprague–Dawley rats, as evidenced
by the high level of thiol and catalase activity in lens homogenates. Interestingly, both drugs were
unable to delay progression or reverse lens opacity in the advanced stages of the disease [191],
presumably due to the depletion of the total lenticular antioxidant pool. Maddirala et al. (2017) also
investigated the effect of both topically- and intraperitoneally-administered N-acetylcysteine amide
on selenite-induced cataract formation in male Wistar rat pups [192]. In this experimental model,
Na selenite (19 µM/kg body weight) was administered intraperitoneally on 10th postpartum day,
intraperitoneal N-acetylcysteine amide (250 mg/kg body weight) on ninth, 11th and 13th postpartum
days, while topical N-acetylcysteine drops (1%) was instilled into the eyes from postpartum 15th and
30th days. Interestingly, both intraperitoneal and topical N-acetylcysteine amide attenuated the severity
of cataracts formation, in vivo. Furthermore, the amide-treated lens homogenates exhibited higher
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levels of GSH content, thioltransferase and m-calpain activity, while lipid peroxidation, GSH-Rx activity,
and calcium levels were reduced when compared to selenite-only treated lens homogenates [192].
Carey et al. (2011) also investigated the effect of N-acetylcysteine amide on cataracts induced by the
GSH synthesis inhibitor, BSO, in a Wister rat pup model of the disease. Slit lamp examination of
animal lenses revealed that N-acetyl-cysteine amide prevented cataract formation in 80% of lenses.
Biochemical studies revealed a reduction in lenticular protein carbonylation and lipid peroxidation
while antioxidant defense enzymes were replenished, compared to that of BSO-only treated lenses [193].
In agreement with data from ex vivo studies [116], intraperitoneal administration of acetyl-l-carnitine
prevented selenite-induced cataractogenesis in Wister rat pups, via mechanisms involving inhibition of
lipid peroxidation and restoration of antioxidant content and activity, in vivo [194]. N-acetylcarnosine,
a prodrug of l-carnosine also attenuated onset and progression of age-related cataracts in humans and
dogs [195], corroborating its effect in lenticular epithelial cells, propolis, delayed onset and progression
of galactose-induced cataract Sprague–Dawley rats, in vivo [117].
Plant-derived compounds and herbal remedies
Plant-derived compounds and herbal remedies have also been reported to demonstrated
anti-cataract potential in studies using experimental animals with this disease. The fruit and
vegetable-derived flavonoid, quercetin, is a potent antioxidant and free radical scavenger that possess
several health benefits, including cardioprotective, anti-diabetic, anti-inflammatory, and anti-cancer
effects, amongst others [196]. As observed in ex vivo studies [91], quercetin prevented the onset and
progression of selenite-induced cataracts and sustained lens chaperone activity in Sprague–Dawley
rats, in vivo [165]. In other studies, intraperitoneal injection of a citrus flavonoid, rutin blocked
selenite-induced lenticular opacification in Wistar rats, with a corresponding elevation in the activity of
the antioxidant enzymes, CAT, SOD, GSH-Px, GST, and GSH-Rx and a reduction in lipid peroxidation,
compared to selenite-only treated lenses [197].
Hesperetin is a flavonoid found in orange rinds that has been reported to elicit beneficial
cardiovascular and anti-inflammatory action effects [198,199]. Hesperetin prevented selenite-induced
cataract formation in rats by attenuating the loss of the lens protein, filensin, and replenishing GSH
and ascorbic acid levels [200]. Furthermore, hesperetin and its derivatives, hesperetin stearic acid ester
and hesperetin oleic acid ester, counteracted the decrease in α-crystallin chaperone activity due to
selenite, in vivo [201,202].
Ellagic acid, a polyphenol found in several plants and fruits such as grapes, nuts, strawberries can
elicit antiproliferative and antioxidant effects, in vitro and in vivo [203–205]. Sakthivel et al. (2008)
showed that ellagic acid mitigated selenite-induced opacification in Wistar rats, in vivo. Ellagic acid
treated lenses exhibited superior CAT, GSH-Px, SOD, GST activities, compared to selenite-only treated
control lenses. Moreover, malondialdehyde and calcium level was lower in ellagic acid treated lenses
compared to untreated selenite group [206].
The leaves and leaf buds of the evergreen shrub, Camellia sinens of the family Theaceae, have been
used for centuries to produce the beverage known as tea. Both green tea and black tea, which are rich
in polyphenols, prevented the onset and progression of lens opacification by restoring antioxidants
in selenite-induced and streptozotocin-induced cataract [121,123,207,208]. The biological effects of
caffeine, a methylxanthine alkaloid found in plants and used as a beverage worldwide, has been
extensively described in literature [209,210]. There is evidence supporting a protective role for caffeine
from UV radiation-induced cataractogenesis, in vivo. Indeed, topically administered caffeine mitigated
UV radiation-induced cataractogenesis and lens apoptosis in Sprague–Dawley rats [211–213]. Moreover,
coffee delayed onset of selenite-induced cataract in rats and preserved antioxidant enzymes and lens
protein [165,214]. Caffeine and pyrocatechol also sustained lens chaperone activity in selenite-induced
Sprague–Dawley rat lenses, in vivo [165].
Other dietary antioxidants have been extensively explored in the prevention of cataract formation,
in vivo. The carotenoids (α-carotene, β-carotene, lutein, lycopene, and cryptoxanthin) were shown to
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elicit a protective action from both oxidative stress- and hyperglycemia-induced cataract formation,
in vivo [165,215–217]. Nakazawa et al. (2017) also demonstrated that both oil-soluble (e.g., β-carotene,
lutein, zeaxanthin, anthocynain) and water-soluble (e.g., cyanidin) antioxidants could impede the onset
and progression of selenite-induced cataracts and sustain lens chaperone activity in Sprague–Dawley
rats, in vivo [165]. Curcumin is a bright yellow compound with antioxidant properties and is produced
from the Curcuma longa plant belonging to the Zingiberaceae family. Curcumin delayed the initiation
and progression of galactose-, oxidative stress- and streptozotocin-induced cataract formation, in vivo,
by mechanisms that involved the preservation of lenticular antioxidant, lipid peroxidation, and soluble
protein content [218–221].
Resveratrol (3,5,40 -trihydroxy-trans-stilbene) is a natural phenolic stilbenoid present in the skin of
grapes, blueberries, raspberries, mulberries, and peanuts [222,223]. Resveratrol has been reported to
possess health benefits in several chronic diseases such as diabetes mellitus, various cancers, metabolic
syndrome, cardiovascular diseases, and Alzheimer’s disease, to mention a few [223,224]. Resveratrol
prevented selenite-induced cataract in Sprague–Dawley rat pups, as evidenced by the optical clarity of
lenses and higher GSH and reduction in lipid peroxidation in resveratrol-treated lenses [225].
Heliotropium indicum, also known as Indian heliotrope, is a plant that belongs to the family
Boraginaceae. In some parts of Asia, its leaf extracts are used as a traditional remedy for wounds,
skin ulcers, conjunctivitis and cataracts, amongst others [226,227]. Whole plant aqueous extracts of
Heliotropium indicum prevented selenite-induced cataractogenesis in Sprague–Dawley rats, in vivo.
In addition to preserving aquaporin 0, crystallins (αA &αB), total lens proteins, and GSH contents,
its aqueous extracts attenuated lipid peroxidation, suggesting an antioxidant basis for its anti-cataract
activity [228].
Echium amoenum, a perennial plant that also belongs to the Boraginaceae family, has been shown to
possess antimicrobial, antidiabetic, and anxiolytic properties, amongst others [229]. Hydroalcoholic
extract of Echium amoenum also elicited a protective effect against selenite-induced lens opacification
in rats, in vivo. These investigators concluded that the antioxidant phytochemicals within the plant
accounted for the anti-cataract activity of Echium amoenum [230].
IH636 grape seed proanthocyanidin extract (GSPE), an oligomeric proanthocyanidin extracted
from grape seeds, has been shown to possess potent free radical scavenging and antioxidant properties
with several potential health benefits [231,232]. IH636 GSPE attenuated cataract formation in
Sprague–Dawley rat pups, most likely through the antioxidant actions of the extract [233].
Cassia tora, also known as sennatora, is a herbaceous plant that belongs to the Fabaceae family,
has a wide application ranging from edible vegetable, food additive, medicinal (laxative, treatment
for skin disease, antiparasitic) to industrial (cassia gum—a thickener and gelling agent) use [234].
Cassia tora leaves delayed the onset and progression of cataract formation in neonatal rats. In addition
to preserving the antioxidant defense system, lens morphology and the expression of lens crystallins,
Cassia tora attenuated lipid peroxidation, compared to selenite-only treated lenses [235,236].
Vaccinium corymbosum (northern highbush blueberry), a deciduous shrub that belongs to the
family Ericaceae, has been shown to be rich in vitamin C and polyphenol antioxidants [237]. A decoction
of Vaccinium corymbosum leaf attenuated the onset and progression of selenite-induced cataracts in
neonatal rats [238]. Lenses from the decoction-treated animals exhibited significantly higher levels of
antioxidant markers and soluble proteins while protein aggregation and activation of calpain were
mitigated [238].
Emilia sonchifolina (also known as “lilac tassel flower”), a tropical plant that belongs to the Asteraceae
family, is used as a herbal remedy for ocular ailments, fever, sore throat, diarrhea, eczema, and as
an antidote for snake bites in some Asian countries [239,240]. Lija et al. (2006) found that Emilia
sonchifolia-derived flavonoids prevented the initiation and progression of selenite-cataract formation,
in vivo. In addition to enhancing activities of SOD, CAT, GSH enzymes, the flavonoids reduced lipid
peroxidation compared to selenite-only treated animals, suggesting that antioxidant mechanisms
account for the anti-cataract effect of Emilia sonchifolia-derived flavonoids [241].
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Broccoli (Brassica oleracea var. italic), a common vegetable that belongs to the family Brassicaceaeis,
is naturally enriched with nutritional antioxidants and flavonoids [242]. Broccoli has been reported to
possess several health benefits such as decreasing the risk of cancer [243]. Broccoli-derived flavonoid
fraction attenuated the onset and progression of selenite-induced lens opacification with corresponding
higher GSH content, activity of antioxidant enzymes (CAT, SOD) and a reduction in lipid peroxidation,
calcium, and calpains when compared to selenite-only treated animals [244].
Lupeol, a pentacyclic triterpenoid present in the flavonoid fraction of Vernonia cinereal plant
that belongs to the Asteraceae family, possesses antimicrobial, anti-inflammatory, and anticancer
activities [245]. Asha et al. (2016) demonstrated an anti-cataract action for lupeol in selenite-induced
Sprague–Dawley rat pups, in vivo. Compared to selenite-only treated animals, lupeol attenuated
selenite-induced lipid peroxidation as well as the decline in the activity of the antioxidant enzymes,
CAT, GSH-Px, GSH-Rx, GST, and Ca2+ ATPase [246].
Allium sativum (garlic) and Allium cepa (onion) are bulbous plants that belong to the Amaryllidaceae
family. Commonly used as a seasoning worldwide, the therapeutic potential of garlic has been reported
to include anti-tumor, cardioprotective, anti-diabetic, antimicrobial, amongst others [247]. In addition
to delaying onset of streptozotocin-induced cataract in Wistar rats, the methanolic Allium sativum
(garlic) extract mitigated hypoglycemia-induced oxidative stress associated with the disease in a
dose-dependent manner and restored lenticular SOD and GSH-Px activities and GSH content [248].
In other studies, the flavonoid-rich, aqueous extract of Allium cepa (onion), preserved optical clarity
in selenite-treated Wistar Albino rats, in vivo. Moreover, the extract treated lenses exhibited higher
total antioxidant level, GSH content, and higher activity of GSH-Px and SOD enzymes compared to
untreated lenses, in vivo [249].
Pinus densiflora, a pine tree that belongs to the family Pinaceae, is naturally enriched with
antioxidant procyanidins and polyphenols [250]. Pinus densiflora has been used as a traditional remedy
for inflammation and pain in some Asian countries [251]. The bark extract of Pinus densiflora prevented
selenite-induced cataract development in Sprague–Dawley rat pups in a dose-dependent manner [252],
with a corresponding enhancement of lenticular water-soluble protein and GSH contents; antioxidant
activities of SOD, GSH-Px, and CAT enzymes; and a reduction in water-insoluble protein content
and lipid peroxidation. Furthermore, the extract counteracted the selenite-induced downregulation
of αA-crystalline, lens-specific m-calpain (Lp84), filensin and phakinin, and the antiapoptotic factor
(Bcl-2), and the upregulation of apoptotic proteins [252]. In other studies, Ocimum sanctum delayed
the onset and incidence of selenite-induced cataracts, and preserved antioxidants and soluble protein
contents in rat lenses, in vivo [153].
Crocus sativus, commonly known as saffron crocus, is a flowering plant that belongs to the Iridaceae
family. The Crocus sativus stigma, which is enriched with nutrients such as flavonoids, crocetin,
and crocin is widely used as a spice and a traditional medicinal remedy for various ailments such as
stomach pain [253]. Aqueous extract of Crocus sativus stigma prevented selenite-induced cataracts
in rats and enhanced the antioxidant enzymes SOD, CAT, GSH-Px, and GSH content. Additionally,
the extract attenuated lenticular selenite-induced lipid peroxidation, protein oxidation, and proteolysis,
thereby affirming the antioxidant-based mechanism for the anti-cataract action of the plant [254].
The plants, Pterocarpus marsupium and Trigonellafoenum-graceum, which belong to the Fabaceae family
are found to have traditional application as anti-diabetic remedies [255]. Therefore, Vat et al. (2004)
sought to investigate the possible application of these plants to prevent diabetic cataracts and
found that the aqueous extracts of the bark of Pterocarpus marsupium and the alcoholic extract of
the Trigonellafoenum-graceum seeds displayed an anti-cataract effect in alloxan-diabetic rats, in vivo.
Moreover, the anti-cataract potency was directly proportional to the hypoglycemic potency of the
plants, leading the authors to conclude that the hypoglycemic capacity of the plants was responsible
for the anti-cataract effect observed [256].
Ginkgo biloba, a tree from the family Ginkgoaceae, has been used for centuries as a traditional remedy
for various ailments such as cough and asthma in some Asian countries [257,258]. Oral supplementation
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with an extract of Ginkgo biloba delayed the onset and progression of cranial radiation-induced cataract
formation and abolished the corresponding reduction in SOD and GSH-Px activities and increase in
lipid peroxidation in Sprague–Dawley rats, in vivo [259]. For further details, the reader is referred to
the rigorous review by Thiagarajan and Manikandan, focused on the anti-cataract activity of vitamin
C, vitamin E, and curcumin along with prototype plant materials with antioxidant activities tested
against cataracts [260].
Gupta et al. (2010) investigated the pharmacological actions of Triphala, consisting of Emblica
officinalis, Terminalia chebula, and Terminalia belerica on selenite-induced cataract in Wistar rats in vivo.
In corroboration with its ex vivo effects, the herbal combination blocked the progression and intensity of
selenite-induced cataracts, in vivo [132]. In summary, various plant extracts and products that possess
antioxidant properties have tremendous potential in the development of anti-cataract medications.
Table 4 provides a summary of antioxidant drugs that elicit an anti-cataract effect on various models of
the disease, in vivo.
4.2.2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
In the 800 s NSAIDs emerged as potential anti-cataract agents after aspirin was found to have
anti-cataract effect in a rheumatoid arthritis study [261]. Subsequently, aspirin and variety of NSAIDs
such as ibuprofen, naproxen, sulindac, bendazac, 5-hydroxybendazac, and bendazac-lysine were
pursued for their anti-cataract activity [262–271]. These observed anti-cataract activities of NSAIDS
were due to different mechanisms such as acetylation, inhibition of glycosylation, and carbamylation
of lens proteins [262]. Sulindac possessed anti-cataract activity, possibly due to aldose reductase
inhibition [272] while naproxen had effect on galactose-induced and selenite-induced cataract in
rats [273,274]. Naproxen reversed depletion of GSH and high malondialdehyde levels due to oxidant
stress induced lipid peroxidation in isolated rat lens [275]. Although some studies implicate the
inhibition of aldose reductase for the anti-cataract activity of NSAIDs other studies indicate antioxidant
properties, suggesting an array of pathways [7,262–274]. However, no recent studies have surfaced in
the past few years in supporting an anti-cataract role for NSAIDs besides their common post-cataract
surgery use to prevent cystoid macular edema [276,277].
4.2.3. Miscellaneous Drugs
In addition to antioxidants, various miscellaneous compounds have exhibited an anti-cataract effect.
Pharmacological chaperons that bind α-crystallins (cryAA and cryAB) reversed protein aggregation in
various models of cataracts. For example, compound 29 (5-cholesten-3b,25-diol) prevented protein
aggregation and enhanced protein solubility, thereby improving lens clarity in severe age-related
cataracts (R120G cryAB knock-in mice), hereditary cataract due to a mutation (R49C cryAA knock-in
mice), and age-related cataract (C57BL/6J wild-type mice) [278].
Angiotensin-converting enzyme (ACE) inhibitors, lisinopril and enalapril, have been reported
to elicit anti-cataract activities in glucose-induced cataract, probably due to the antioxidant and
free radical scavenging mechanisms [279]. Enalapril and lisinopril were also able to retard the
glucose (55 mM)-induced opacification in goat lenses cultured in artificial aqueous humor, ex vivo.
Contrary to ACE-treated lenses in which Na+ -K+ -ATPase activity and total protein content was higher,
the glucose-only treated lenses displayed a higher level of lipid peroxidation [279].
Ursodeoxycholic acid, a component of bear bile, similarly prevented selenite-induced cataract
formation on M-199 cultured Wister rat lenses, ex vivo [280]. Hydrogen saline and ursodeoxycholic
acid were able to elevate the total antioxidative capabilities and activity of SOD, CAT, GSH-Px,
GSH-Rx, and GST compared to untreated lenses following selenite insult, ex vivo. Moreover,
the contents of sulfhydryl groups and GSH were higher in hydrogen saline- and ursodeoxycholic
acid-treated lenses as compared to the selenite-only treated group, which displayed higher lenticular
malondialdehyde [280,281].
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Table 4. Summary of in vivo studies of cataractogenesis.
Drug

Cataract Stimuli

Animal Model

Mode of Application

Pharmacological Action

Ref

Sodium selenite
(20 µmol/kg)

White New Zealand
rabbits

Subcutaneous
injection

Decreased cataractogenesis by 40%

[162]

Sprague–Dawley rats

Subcutaneous
injection

Subcutaneous 0.1 mL of vitamin C (0.3 mM) injection
on 8th day postpartum increased concentration of total
protein and soluble protein. Comparable
electrophoretic pattern of lens proteins to untreated.

[163]

[164]

Sodium selenite,
100 µL of 20 µmol/kg
Vitamin C
(Ascorbic acid)

Antioxidants

10% dietary galactose

Guinea pigs

Dietary

Intensified the loss of Na+ -K+ ATPase activity in the
lens capsule-epithelium caused by galactose feeding.
Oxidized GSH was not detectable in the lens capsule
epithelia. Hexose monophosphate shunt activity was
not elevated in lenses of pigs during the first hour of
culture after euthanasia

Sodium selenite
(20 µmol/kg)

Sprague–Dawley rats

Dietary

Ascorbic acid attenuated onset of cataract and loss in
chaperone activity.

[165]

Sodium selenite
(20 µmol/kg)

Sprague–Dawley rats

Subcutaneous
injection

Vitamin E attenuated selenite-induced onset of cataract
and the corresponding loss in chaperone activity.

[165]

Prednisolone acetate

Brown–Norway rats

Eye drops

Vitamin E attenuated steroid-induced cataract
formation probably due to its antioxidant effect and on
the stability of the lens fiber membrane.

[167]

Ultraviolet B (UVB)
radiation

Albino
Sprague–Dawley rats

Dietary

Vitamin E attenuated intensity UVB-induced opacity
and enhanced lenticular GSH content.

[169]

Streptozotocin
(55 mg/kg)

Wistar rats

Dietary

Vitamin E delayed onset of advanced cataracts

[171]

Vitamin E- and
selenium

SDZ ICT 322 (selective
5-HT3 antagonist)

Wistar rats

Dietary

Deficiency of vitamin E and selenium accelerated onset
of cataracts and enhanced lipid peroxidation

[168]

Alpha-lipoic acid

Fructose

Sprague–Dawley
albino rats

Gavage

Retarded onset and progression of cataract. Increased
CAT, SOD, GSH-Px, GSH and total protein. It also
increased activity of Ca2+ ATPase activity while it
reduced malondialdehyde and Ca2+ .

[172]

l-buthionine(S,R)sulfoximine

Sprague–Dawley rats

Intraperitoneal
injection

Increased lenticular GSH, ascorbate, and vitamin E.

[173]

Streptozotocin
(55 mg/kg)

Wistar rats

Dietary

Reduced plasma malondialdehyde and replenished
lenticular Sulfhydryl groups.

[171]

Vitamin E

Stobadine
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Table 4. Cont.
Drug

Minerals and
trace elements

Cataract Stimuli

Animal Model

Mode of Application

Pharmacological Action

Ref

Intraperitoneal
injection

Inhibited cataract formation in rats evidenced with
increased total GSH possibly due to its free radical
property or stimulated GSH production.

[178]

Melatonin
(4 mg/Kg)

Buthionine sulfoximine
(3 mmol/kg)

New born rats

Zinc sulfate

Sodium selenite

Rabbits

Eye drops

Retard opacities progression and lowered opacity score.

[183]

Ebselen

Sodium selenite
(30 nmol/kg)

Sprague–Dawley rat s

Subcutaneous
injection

Increased GSH levels while it lowered
malondialdehyde levels and total nitrite level.

[187]

Sodium pyruvate

streptozotocin
(55 mg/kg)

Sprague–Dawley rats

Dietary

Decreased levels of glycated proteins, sorbitol,
malondialdehyde while it increased activity of the
cation pump.

[188]

Pyruvate

Sodium selenite
(0.5 µmoles)

Sprague–Dawley rats

Intraperitoneal
injection

It prevented cataractogenesis and its level was
increased in the aqueous humor.

[105]

l-cysteine

Sodium selenite, 100 µL
of 20 µmol/kg

Sprague–Dawley rats

Subcutaneous
injection

Subcutaneous 0.1 mL of l-cysteine (0.05 µmol) on 8th
day postpartum increased concentration of total
protein and soluble protein. Comparable
electrophoretic pattern of lens proteins to untreated.

[158]

Sodium selenite
subcutaneously
(30 nmol/g).

Sprague–Dawley rat

Intraperitoneal
injection

Reduced cataract formation by 71.4%. Increased
lenticular and serum GSH while reducing lenticular
protein carbonyl and lenticular and serum
malondialdehyde level.

[189]

Triamcinolone
acetonide (1 mg)

Wistar–Albino rats

Intraperitoneal
injection

Increased lenticular GSH and GSH-Px while it reduced
the level of protein carbonyl and malondialdehyde.

[190]

Streptozotocin
(65 mg/kg)

Sprague–Dawley rats

Eye drops

Inhibited cataract progression at an early after which
activity declined. Did not increase GSH-Px and CAT.
Increased glycation levels and thiols.

[191]

l-buthionine-(S,R)sulfoximine

Wistar rats

Intraperitoneal
injection

Replenished GSH levels of replenished and limited
protein carbonylation, lipid peroxidation, and redox
system components.

[193]

Sodium selenite

Wistar rats

Intraperitoneal
injection

Reversed cataract grade. Increased GSH level,
thioltransferase activity, m-calpain activity, and
m-calpain levels while it reduced malondialdehyde
level, GSH-Px enzyme activity, and calcium levels

[192]

Sodium selenite

Wistar rats

Eye drops

Reversed cataract grade. Increased GSH level,
thioltransferase activity, m-calpain activity, and
m-calpain levels while it reduced malondialdehyde
level, GSH-Px enzyme activity, and calcium levels

[192]

N-acetylcysteine
Ketoacids and
amino acids
N-acetylcysteine
amide and GSH
ethyl ester

N-acetylcysteine
amide
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Table 4. Cont.
Drug

Plant-derived
compounds
and herbal
remedies

Cataract Stimuli

Animal Model

Mode of Application

Pharmacological Action

Ref

[194]

Acetyl-l-carnitine

Sodium selenite

Wistar rats

Intraperitoneal
injection

Increased GSH content as well as GST and GSH-Px
activity while it lowered malondialdehyde level. It also
increased staining intensity of isozyme bands for SOD
and GSH-Px.

water-insoluble antioxidants
(lutein, zeaxanthin hesperetin,
quercetin, anthocyanin,
β-carotene, and α-tocopherol)
and water-soluble antioxidants
(ascorbic acid, cyanidin)

Sodium selenite
(20 µmol/Kg)

Sprague Dawley
rats

Subcutaneous
injection

Maintained activity of chaperone activity in water
soluble lens proteins.

[165]

Rutin

Sodium selenite
(19 µmol/kg)

Wistar rats

Intraperitoneal
injection

Inhibited lipid peroxidation and increased activity of
SOD, CAT, GSH-Px, and, GST.

[197]

Hesperetin (flavonoid)

Sodium selenite
(20 µmol/Kg)

Sprague–Dawley
rats

Subcutaneous
injection

Increased expression of the of filensin (94 and 50 kDa
forms). Interestingly, these forms of filensin Increased
lenticular GSH and ascorbic acid levels.

[200]

Hesperetin (flavonoid) and
derivatives

Sodium selenite
(20 µmol/Kg)

Sprague–Dawley
rats

Subcutaneous
injection

Mitigated decreased lens chaperone activity and
α-crystallin water solubility.

[201,202]

Ellagic acid

Sodium selenite
(19 µmol/kg)

Wistar rats

Intraperitoneal
injection

Lenticular and erythrocytic GSH were increased while it
reduced lenticular malondialdehyde and calcium content.

[206]

Green tea (Camellia sinensis)

Sodium selenite
(0.25 µmol/Kg)

Wistar rats

Intraperitoneal
injection

Decreased cataractogenesis by 66.67%

[207]

Sodium selenite
(2.2 mg/kg)

Wistar rats

Subcutaneous
injection

Scavenged reactive oxygen species and prevented
oxidative cross-linking of proteins and single strand
breakage of DNA.

[207]

Streptozotocin
(65 mg/Kg)

Sprague–Dawley
rats

Drinking water

Hypoglycemic effect retreaded cataract formation.

[208]

Ultra-violate-B
radiation

Sprague–Dawley
rats

Eye drops

Reduced caspase-3 and lens sensitivity to ultra-violate-B
by 1.23 times.

[211]

Sodium selenite
(15 µmol/kg)

Sprague–Dawley
rats

Gastric intubation

Reduced lenticular level of malondialdehyde, total nitric
oxide, Ca+-ATPase, tumor necrosis factor-α,
interleukin-1β, SOD, while it increased lenticular total
protein, reduced GSH, and CAT.

[212]

Sodium selenite
(20 µmol/Kg)

Sprague–Dawley
rats

Subcutaneous
injection

Maintained activity of chaperone activity in water
soluble lens proteins.

[165]

Green or black tea extracts

Caffeine

Caffeine and pyrocatechol
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Table 4. Cont.
Drug

Cataract Stimuli

Animal Model

Mode of Application

Pharmacological Action

Ref

Sprague–Dawley rats

Subcutaneous
injection

Maintained activity of chaperone activity in water
soluble lens proteins.

[165]

Wistar rats

Intraperitoneal
injection

Reduced selenite induced cataract by 89% and reduced
onset and progression of galactose induced cataract
was observed with oral feeding of lycopene. Only 35%
of the eyes developed mature cataract as opposed to
100% in the control group

[217]

Dietary 30% galactose

Wistar rats

Intraperitoneal
injection

Reduced selenite induced cataract by 89% and reduced
onset and progression of galactose induced cataract
were observed with oral feeding of lycopene. Only 35%
of the eyes developed mature cataract as opposed to
100% in the control group

[217]

Galactose (30%)

Sprague–Dawley rats

Dietary

Augmented GSH while it reduced malondialdehyde
levels. It also inhibited advanced glycation end product
formation and protein aggregation.

[218]

Sodium selenite
(30 µM/Kg)

Wistar rats

Subcutaneous
injection

Increased activity of SOD and CAT while it reduced
malondialdehyde levels and xanthine oxidase activity.

[219]

Sodium selenite
(15 µM/Kg)

Wistar rats

Intraperitoneal
injection

Reduced malondialdehyde levels while it increased
SOD, GSH-Px, GST, and CAT activity.

[220]

Streptozotocin
(35 mg/Kg)

WNIN rats

Dietary

Reduced malondialdehyde levels, increased reduced
GSH, protein carbonyl content and activities of
peroxide dismutase, GSH-Px, and glucose-6-phosphate
dehydrogenase

[221]

Turmeric

Streptozotocin
(35 mg/kg)

Wistar–NIN rats

Dietary

Reduced lipid peroxidation and protein carbonyl
content while it increased GSH and antioxidant
enzyme activities.

[221]

Resveratrol

Sodium selenite
(30 nmol/g)

Spraque–Dawley rats

Subcutaneous
injection

Increased lenticular and erythrocytic GSH and lowered
malondialdehyde levels.

[225]

Heliotropiumindicum
extract

Sodium selenite
(15 µmol/kg)

Sprague–Dawley rats

Oral

Preserved epithelial and lens fiber integrity, aquaporin
0, alpha A and B crystallins, total lens proteins, and
lenticular GSH levels. It also showed free radicals
scavenging activity and inhibited lipid peroxidation.

[228]

Hydroalchoholic extract
of Echium amoenum

Sodium selenite
(30 nmol/kg)

White rats

Intraperitoneal
injection

Improved cataract grade and optical clarity of lenses.

[230]

β-carotene

Sodium selenite
(20 µmol/Kg)

Dietary 30% galactose
Lycopene

Curcumin
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Table 4. Cont.
Drug

Cataract Stimuli

Mode of Application

Pharmacological Action

Ref

Spraque–Dawley rats

Oral

Increased lenticular GSH content and reduced
malondialdehyde.

[233]

Sodium selenite
(4 µg/g)

Spraque–Dawley rats

Oral

Reduced oxidative stress index, prevented structural
crystallin loss, and increased total peroxide level.

[235,236]

Vaccinium corymbosum leaf
decoction (chlorogenic acid,
quercetin, rutin, isoquercetin
and hyperoside)

Sodium selenite
(20 µmole/Kg)

White rats

Intraperitoneal
injection

Prevented oxidative attack and calpain activation,
protein loss and aggregation.

[238]

Emilia sonchifolia (flavonoid
fraction)

Sodium selenite
(4 mg/kg)

Rat

Intraperitoneal
injection

Increased GSH, activities of SOD and CAT while
thiobarbituric acid reacting substances were reduced.

[241]

Brassica oleracea var. italica
(flavonoid fraction)

Sodium selenite
(4 mg/kg)

Sprague–Dawley rats

Intraperitoneal
injection

Increase SOD, CAT, GSH, Ca2+ ATPase while it
reduced, calcium, calpains and lipid peroxidation
product-thiobarbituric acid reacting substances

[244]

Lupeol, a flavonoid from the
plant, Vernonia cinereal plant

Sodium selenite
(25 µg/g)

Sprague–Dawley rats

Oral

Reduced lipid peroxidation and protein oxidation.
Upheld activity of. Lenticular SOD, CAT, GSH-Px,
GSH-Rx, GST, and GSH content.

[246]

Methanolic extract of
Allium sativum

Streptozotocin
(34 mg/kg body
weight)

Wistar rats

Forced gut- feeding

Delay in onset of cataracts; Restoration of lenticular
GSH, GSH-Px and SOD activities

[248]

Aqueous extract of
Allium cepa

Sodium selenite
(30 nmol/g body
weight)

Wistar albino rats

Eye drops

The allium aqueous extract of garlic preserved optical
clarity; Allium-treated lenses exhibited higher total
antioxidants and higher GSH-Px and SOD activities

[249]

[252]

H636 grape seed
proanthocyanidin extract

Sodium selenite
(30 nmol/g)

Cassia tora Linn. leaves

Animal Model

Pinus densiflora bark extract

Sodium selenite
(18 µmol/kg)

Sprague–Dawley rats

Gastric intubation

Increased water-soluble protein and GSH content, SOD,
GSH-Px, and CAT activity while it lowered
water-insoluble protein, malondialdehyde, and
Ca2+ -ATPase. It inhibited m-calpain-induced
proteolysis and apoptosis.

Ocimum sanctum

Sodium selenite
(25 µmole/kg)

Wistar rats

Intraperitoneal
injection

Prevented lens protein insolubilization.

[153]

Crocus sativus stigmas
(saffron) extra

Sodium selenite
(20 µmol/kg)

Wistar rats

Intraperitoneal
injection

Increased activities of SOD, GSH-Px, CAT and GSH
content. Halted lipid peroxidation, protein oxidation,
and proteolysis and insolubilization of water-soluble
proteins.

[254]
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Propolis

d-galactose
(15% or 25%)

Sprague–Dawley
albino rats

Oral (dietary)

Reduced reactive oxygen species and improved
epithelial cell viability.

[117]

An aqueous extract of Pterocarpus
marsupium Linn bark and alcoholic
extract of Trigonellafoenum-graecum
Linn seeds

Alloxan
120 mg/Kg

Rats

Gastric tube

Showed antihyperglycemic effect and reduced opacity
index.

[256]

Ginkgo biloba

Total-cranium
irradiation (5 Gy)

Sprague–Dawley
rats

Oral

Increase the activities of SOD and GSH-Px while it
reduced and significantly decreased malonaldehyde
content.

[259]

A herbal preparation-Triphala
(Emblica officinalis, Terminalia
chebula, and Terminalia belerica)

Sodium selenite
(100 µM)

Wistar rat lenses

Intraperitoneal
injection

Delayed onset and progression of cataracts

[132]
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Posterior capsular opacification is a common secondary complication to cataract surgery that
involves intraocular lens implantation with an artificial intraocular lens [282]. Sternberg et al. (2010)
investigated a method to prevent secondary cataract in New Zealand rabbits after implantation
of intraocular lens, in vivo [283]. Compared to control animals that developed opacification in
six weeks, these investigators demonstrated that treatment with methotrexate and actinomycin
D mixture loaded hyaluronic acid delayed opacification up to six months, postoperatively [283].
In other studies, a sustained cyclosporin A delivery microsphere prevented postoperative posterior
subcapsular cataract development in New Zealand white rabbits, in vivo [284]. Brown and Akaichi
(2015) observed an association between vitamin D deficiency and posterior subcapsular cataract
patients and suggested that intake of vitamin D might reduce incidence of posterior subcapsular
cataracts [285]. In corroboration, lanosterol, a crucial intermediate in the biosynthesis of steroids and
vitamin D, reduced protein aggregation due to mutant crystallin in in vitro tests and cell transfection
methods. Moreover, lanosterol attenuated cataract and increased lens transparency in cataractous
lenses from rabbits and dogs, thus diminishing severity of cataract, in vivo [286]. Taken together, these
studies suggest a significant role for vitamin D in lens transparency.
5. Conclusions
Although cataract has been the leading cause of preventable blindness worldwide for many
decades, pharmacological strategies to mitigate, prevent, or cure this blinding disease have remained
elusive. With the projected increase in life expectancies, the number of people affected with cataract
is predicted to increase worldwide. The prognosis of the disease is at best oblique in low income
nations that lack easy and affordable access to cataract surgery. Therefore, the potential therapeutic and
economic benefits of pharmacological cataract treatments are immeasurable, ranging from a reduction
in economic burden to better quality of life. This review presents a wide range of compounds, including
antioxidants and herbal remedies/extracts that have exhibited anti-cataract activity in vitro, ex vivo,
and in vivo. So far, compounds that possess antioxidant and free radical scavenging activity have
shown tremendous potential in these experimental studies. The ready accessibility of plant-derived
compounds/mixtures renders them an attractive treatment choice, especially in developing nations
where cost is likely to hinder the development and patient use of medication. However, none of
these drug candidates have translated into US FDA-approved anti-cataract eye drops or remedies that
can prevent, deter, or cure cataracts in humans. Therefore, further research is necessary to establish
efficacy and safety profile of these herbal remedies and antioxidants, standardize drug formulations,
and conduct double-blinded studies to justify clinical application in humans. It is interesting
to note that the Age-Related Eye Disease Study 2 (AREDS2) failed to demonstrate a significant
deterrent in the progression of age-related cataract using lutein/zeaxanthine supplementation [287].
Similarly, an extensive Cochrane review did not identify a significant anti-cataract effect of vitamin
supplementation in humans [288]. It is conceivable that improvement in drug delivery strategies could
enhance anti-cataract efficacy in the prevention and/or treatment of cataracts. Additionally, there is a
need to delineate the exact mechanisms involved in the process of formation of cataracts in order to
identify new therapeutic targets and new drug candidates that can be refined for therapeutic and/or
prophylactic use in humans.
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Abbreviations
ACE
ATPase
BSO
CAT
CNS
Cu
EC
EGCG
GSH
GSH-Px
GSPE
GSH-Rx
GSSG
GST
K+
Mn-SOD
Na+
Na+ -K+ -ATPase
NADPH
NSAIDs
SOD
TGF-β
UV
UVA
UVB
Zn

Angiotensin converting enzyme
Adenosine triphosphatase
Buthionine sulfoximine
Catalase
Central nervous system
Copper
Extracellular
Epigallocatechin-3-gallate
Glutathione
Glutathione peroxidase
Grape seed proanthocyanidin extract
Glutathione reductase
Glutathione disulfide
Glutathione-S-Transferase
Potassium cation
Mitochondrial-superoxide dismutase
Sodium cation
sodium-potassium adenosine triphosphatase
Nicotinamide adenine dinucleotide phosphate
Non-steroidal anti-inflammatory drugs
Superoxide dismutase
Transforming growth factor beta
Ultraviolet
Ultraviolet A
Ultraviolet B
Zinc
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